Off-the-shelf human umbilical cord mesenchymal stromal cell product in acute-on-chronic liver failure: A multicenter phase I/II clinical trial
- PMID: 40789660
- DOI: 10.1097/CM9.0000000000003768
Off-the-shelf human umbilical cord mesenchymal stromal cell product in acute-on-chronic liver failure: A multicenter phase I/II clinical trial
Similar articles
-
Salvage treatment of steroid-refractory acute GVHD with the off-the-shelf product of human umbilical cord mesenchymal stromal cells: a multicenter, open label, phase Ib/IIa trial.Stem Cell Res Ther. 2025 Jul 1;16(1):345. doi: 10.1186/s13287-025-04446-8. Stem Cell Res Ther. 2025. PMID: 40597363 Free PMC article. Clinical Trial.
-
Allogeneic umbilical cord-derived mesenchymal stromal cells as treatment for systemic lupus erythematosus: a single-centre, open-label, dose-escalation, phase 1 study.Lancet Rheumatol. 2025 Apr;7(4):e261-e273. doi: 10.1016/S2665-9913(24)00298-4. Epub 2024 Dec 17. Lancet Rheumatol. 2025. PMID: 39706212 Clinical Trial.
-
Umbilical Cord Matrix (Wharton Jelly) Mesenchymal Stem Cells in Next-generation Myocardial Repair and Regeneration: Mechanisms and Pre-clinical Evidence.Curr Cardiol Rev. 2025;21(5):76-103. doi: 10.2174/011573403X372908250117092252. Curr Cardiol Rev. 2025. PMID: 40012283 Review.
-
Treatment of COVID-19-associated ARDS with umbilical cord-derived mesenchymal stromal cells in the STROMA-CoV-2 multicenter randomized double-blind trial: long-term safety, respiratory function, and quality of life.Stem Cell Res Ther. 2024 Apr 19;15(1):109. doi: 10.1186/s13287-024-03729-w. Stem Cell Res Ther. 2024. PMID: 38637891 Free PMC article. Clinical Trial.
-
Granulocyte colony-stimulating factor with or without stem or progenitor cell or growth factors infusion for people with compensated or decompensated advanced chronic liver disease.Cochrane Database Syst Rev. 2023 Jun 6;6(6):CD013532. doi: 10.1002/14651858.CD013532.pub2. Cochrane Database Syst Rev. 2023. PMID: 37278488 Free PMC article.
References
-
- Li Y, Xu Y, Wu H, Yang J, Yang L, Yue-Meng W. Umbilical cord-derived mesenchymal stem cell transplantation in hepatitis b virus related acute-on-chronic liver failure treated with plasma exchange and entecavir: A 24-month prospective study. Stem Cell Rev Rep 2016;12:645–653. doi: 10.1007/s12015-016-9683-3. - DOI
-
- Shi M, Zhang Z, Xu R, Lin H, Fu J, Zou Z, et al. Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients. Stem Cells Transl Med 2012;1:725–731. doi: 10.5966/sctm.2012-0034. - DOI
-
- Liver Failure and Artificial Liver Group; Chinese Society of Infectious Diseases; Chinese Medical Association; Severe Liver Disease and Artificial Liver Group; Chinese Society of Hepatology; Chinese Medical Association. Guideline for diagnosis and treatment of liver failure (in Chinese). Chin J Hepatol 2019;27:18–26. doi: 10.3760/cma.j.issn.1007-3418.2019.01.006. - DOI
-
- Lin B, Chen J, Qiu W, Wang K, Xie D, Chen X, et al. Allogeneic bone marrow-derived mesenchymal stromal cells for hepatitis B virus-related acute-on-chronic liver failure: A randomized controlled trial. Hepatology 2017;66:209–219. doi: 10.1002/hep.29189. - DOI
-
- Schacher FC, Martins Pezzi da Silva A, Silla L, Alvares-da-Silva MR. Bone marrow mesenchymal stem cells in acute-on-chronic liver failure grades 2 and 3: A phase I-II randomized clinical trial. Can J Gastroenterol Hepatol 2021;2021:3662776. doi: 10.1155/2021/3662776. - DOI
LinkOut - more resources
Full Text Sources